Pharma Journalist 8903 posts 0 comments

GSK plc and BELLUS Health Inc. announced GSK has completed the acquisition of BELLUS, a biopharmaceutical company working to better the lives of patients suffering from refractory…
Read More...

Japanese pharmaceutical company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organisation, have today announced…
Read More...

AstraZeneca’s Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has been approved by China’s National Medical Products…
Read More...

GSK plc announced the US Food and Drug Administration (FDA) has granted a Fast Track designation for its Neisseria gonorrhoeae investigational vaccine (NgG). The vaccine candidate is…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for fidanacogene elaparvovec for the treatment of…
Read More...

Xentria Inc., a clinical-stage biotherapeutics company focused on developing therapeutics to address unmet clinical needs, and Meitheal Pharmaceuticals, Inc., announced an exclusive…
Read More...

The oligonucleotide industry needs collaboration between biopharma and regulatory experts to optimize manufacturing processes, develop robust analytical methods, and ensure the quality…
Read More...

Innovent Biologics, Inc. and RemeGen Co., Ltd. announced that they entered into a clinical trial collaboration and supply agreement with for the combination therapies of TYVYT…
Read More...

Brii Biosciences Limited announced that it entered into definitive agreements with Qpex Biopharma and third parties in connection with the acquisition of Qpex by Shionogi. Under the…
Read More...

Talaris Therapeutics, Inc. and Tourmaline Bio, Inc. announced that the companies have entered into a definitive agreement under which Tourmaline will combine with Talaris in an…
Read More...